Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype
✍ Scribed by Xiaoyan Guo, Zhixin Zhao, Junqiang Xie, Qingxian Cai, Xiaohong Zhang, Liang Peng, Zhiliang Gao
- Book ID
- 118130372
- Publisher
- BioMed Central
- Year
- 2012
- Tongue
- English
- Weight
- 166 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1743-422X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v
To determine the patient-dependent and virusrelated factors that may predict sustained response to interferon-a therapy, we prospectively evaluated 60 consecutive patients with chronic hepatitis C who received a standardized treatment schedule of interferon-a. Twenty-eight patients achieved a long-t